Fibromyalgia: Neuroplastic Pain, Symptoms & Treatment

Last updated August 23, 2026 · 10 min read

By Tauri Urbanik, research writer and PainApp founder

Fibromyalgia is real, even when routine tests are normal

Fibromyalgia can affect far more than pain. Common experiences include fatigue, poor-quality sleep, “fibro fog,” sensory sensitivity, and symptoms that vary from day to day. Routine blood tests and scans do not measure fibromyalgia directly, so normal results should not be used to dismiss those symptoms.

A clinician can diagnose fibromyalgia from the pattern of widespread pain and related symptoms while also checking whether another condition better explains some or all of the picture. New focal weakness, joint swelling, fever, unexplained weight loss, or a major change from your established pattern deserves reassessment.

Is fibromyalgia neuroplastic?

The clearest clinical term is nociplastic pain: pain arising from altered nociception when there is no clear evidence that tissue damage or a nerve lesion fully explains it. Central sensitization is a related mechanism in which pain-processing pathways become more responsive.

“Neuroplastic” is useful because the nervous system is capable of learning and change. But it is a broad biological property, not a diagnosis and not a promise of cure. Fibromyalgia can also involve sleep, autonomic, immune, hormonal, physical, and psychological factors. Different people may have different dominant contributors.

What treatment guidelines actually recommend

The EULAR guideline recommends starting with education and non-drug care. If that is not enough, treatment can be tailored to the person’s main problems: psychological therapies for mood or unhelpful coping patterns, medication for severe pain or sleep disturbance, and multimodal rehabilitation for severe disability. The guideline emphasizes shared decision-making and notes that average effects for most treatments are modest (Macfarlane et al., Annals of the Rheumatic Diseases, 2017↗).

What the EAET trial found—and what it did not

In a cluster-randomized trial, 230 adults with fibromyalgia received eight sessions of Emotional Awareness and Expression Therapy (EAET), cognitive behavioral therapy (CBT), or fibromyalgia education.

EAET did not differ from education on the primary pain-severity outcome. It also did not differ from CBT on the primary or most secondary outcomes. It did outperform education on several secondary measures, and more participants achieved at least 50% pain reduction with EAET than with CBT (22.5% versus 8.3%) (Lumley et al., PAIN, 2017↗).

That makes EAET a reasonable evidence-informed option for some people, particularly when emotional avoidance, trauma, or conflict is clinically relevant. The responder result is encouraging; it is not the same as showing EAET is “three times better” overall.

You can see this trial alongside PRT, CBT, pain education, mindfulness, and long-term evidence in our chronic pain evidence map.

Build a treatment plan around your main barriers

Fibromyalgia treatment is more useful when it answers a specific problem:

• Pain flares after activity: establish a tolerable baseline, then progress gradually rather than cycling between overactivity and prolonged rest.
• Unrefreshing sleep: assess sleep habits and possible sleep disorders; better sleep can improve pain and fatigue.
• Fear of movement or damage: pain education and graded exposure can help rebuild confidence in safe activity.
• Depression, anxiety, trauma, or persistent stress: psychological support may improve both quality of life and pain-related functioning.
• Medication side effects or little benefit: review the target, dose, and alternatives with the prescriber rather than stopping abruptly.
• Several severe limitations at once: coordinated rehabilitation may be more useful than adding isolated treatments.

What recovery can realistically mean

Improvement does not have to be all-or-nothing. Early gains may show up as fewer severe flares, faster recovery after activity, more restorative sleep, clearer thinking, or returning to something meaningful. Some people achieve major pain reduction; others improve function while symptoms remain.

The goal is not to prove that pain is psychological. It is to find modifiable contributors, choose treatments with a clear purpose, and measure whether they help. Our fibromyalgia treatment-options guide goes deeper into this decision process.

Frequently asked questions

Is fibromyalgia neuroplastic or nociplastic pain?

Fibromyalgia is commonly classified as a nociplastic pain condition, meaning altered pain processing contributes to symptoms. Neuroplasticity helps explain how the nervous system can change, but neither term means the pain is imagined or excludes other health conditions.

Can fibromyalgia improve?

Yes, symptoms and function can improve, although there is no single treatment that works for everyone. Guidelines recommend education, individualized non-drug care, and especially exercise, with psychological therapies, medication, or multidisciplinary rehabilitation added according to need.

Does EAET work for fibromyalgia?

One trial of 230 adults found EAET improved several secondary outcomes, and 22.5% achieved at least 50% pain reduction versus 8.3% with CBT. However, EAET did not beat education on the primary pain outcome or CBT on the primary and most secondary outcomes.

What is the best treatment for fibromyalgia?

There is no universally best treatment. EULAR found exercise was the only therapy with a strong recommendation and advised a graduated, shared-decision approach. Treatment is usually matched to pain, fatigue, sleep, mood, and functional goals.

References

1. Macfarlane GJ, et al. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases. 2017;76(2):318-328.DOI: 10.1136/annrheumdis-2016-209724
2. Lumley MA, et al. Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial. PAIN. 2017;158(12):2354-2363.DOI: 10.1097/j.pain.0000000000001036
3. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. PAIN. 2011;152(3 Suppl):S2-S15.DOI: 10.1016/j.pain.2010.09.030